In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

Filed: June 27, 2014

* * * * * * * * * * * * * *

MELISSA DAVIS and CECIL DAVIS, SR.,* UNPUBLISHED

as the Parents and Natural Guardians of * No. 09-684V

C.D., an Infant, *

*

Petitioners, *

* Special Master Dorsey

v. *

* Attorneys’ Fees and Costs;

SECRETARY OF HEALTH * Reasonable Amount Requested to which

AND HUMAN SERVICES, * Respondent Does not Object.

*

Respondent. *

*

* * * * * * * * * * * * *

Mark T. Sadaka, Law Offices of Sadaka Associates, LLC, Englewood, NJ, for petitioners.

Justine E. Daigneault, United States Department of Justice, Washington, DC, for respondent.

ATTORNEYS’ FEES AND COSTS DECISION1

On October 9, 2009, Melissa Davis and Cecil Davis, Sr. (“petitioners”), as the parents

and natural guardians of C.D., an infant, filed a petition pursuant to the National Vaccine Injury 

Compensation Program.2

 42 U.S.C. §§ 300aa-1 to -34 (2006). Petitioners alleged that numerous 

vaccinations, including Pediarix,3 Prevnar,4 and PedvaxHIB,5 that C.D. received on October 18, 

1 Because this decision contains a reasoned explanation for the undersigned’s action in this case, 

the undersigned intends to post this decision on the website of the United States Court of Federal 

Claims, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 

2913 (Dec. 17, 2002). As provided by Vaccine Rule 18(b), each party has 14 days within which 

to request redaction “of any information furnished by that party: (1) that is a trade secret or 

commercial or financial in substance and is privileged or confidential; or (2) that includes 

medical files or similar files, the disclosure of which would constitute a clearly unwarranted 

invasion of privacy.” Vaccine Rule 18(b). Otherwise, the entire decision will be available to the 

public. Id.

2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National 

Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 

42 U.S.C. §§ 300aa-1 to -34 (2006) (Vaccine Act or the Act). All citations in this decision to 

individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa.

3 Pediatrix consists of diphtheria-tetanus-acellular-pertussis (“DTaP”), hepatitis B, and 

inactivated polio virus (“IPV”) vaccines. See Centers for Disease Control & Prevention, 

1

 
2006, caused her to suffer and continue to suffer from “vaccine induced encephalopathy with 

seizures and loss of muscle control, which were either ‘caused-in-fact’ by the above-stated 

vaccinations, or, in the alternative, significantly aggravated by the above-stated vaccinations.” 

Petition at 1. On March 7, 2014, the undersigned entered a decision dismissing the case for 

failure to make a prima facie case.

On June 27, 2014, the parties filed a Stipulation of Facts Concerning Attorneys’ Fees and 

Costs. According to the stipulation, the parties stipulate to an award to petitioners of attorneys’

fees and costs in the amount of $22,650.64. In accordance with General Order #9, petitioners’

counsel represents that petitioners did not personally incur any reimbursable costs in pursuit of 

their claim. 

The Vaccine Act permits an award of reasonable attorneys’ fees and costs. 42 U.S.C. § 

300 aa-15(e). Based on the reasonableness of the parties’ stipulation, the undersigned GRANTS 

the request for approval and payment of attorneys’ fees and costs. 

Accordingly, an award should be made as follows:

in the form of a check jointly payable to petitioner and to Mark T. Sadaka, Esq., of the 

Law Offices of Sadaka Associates, LLC, in the amount of $22,650.64.

In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of 

the court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ 

stipulation.6

IT IS SO ORDERED. 

s/Nora Beth Dorsey

Nora Beth Dorsey

Special Master

Pediarix Vaccine: Questions and Answers, http://www.cdc.gov/vaccines/vpd-vac/combovaccines/pediarix/faqs-hcp-pediarix.htm.

4 Prevnar 13 is a pneumococcal conjugate vaccine, also known as PCV 13. See Centers for

Disease Control & Prevention, Pneumococcal Vaccination, available at 

http://www.cdc.gov/VACCINES/vpd-vac/pneumo/default.htm.

5 PedvaxHIB is a Haemophilus influenzae type b vaccine which prevents meningitis (an 

infection of the covering of the brain and spinal cord), pneumonia (lung infection), epiglottitis (a 

severe throat infection), and other serious infections caused by a type of bacteria called 

Haemophilus influenza type b. See Centers for Disease Control & Prevention, Hib Vaccination, 

available at http://www.cdc.gov/Vaccines/vpd-vac/hib/default.htm.

6 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of 

notice renouncing the right to seek review.

2